Literature DB >> 10980996

Therapy for H. pylori infection.

A B Thomson1.   

Abstract

The discovery that peptic ulcers can be caused by gastroduodenal infection with Helicobacter pylori and cured by eradication of this bacterial presence has made a profound impact on ulcer management. This article reviews the principles behind such treatment and the regimens in current use, including proton pump inhibitor triple therapies and ranitidine bismuth citrate triple therapies.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10980996     DOI： 10.1007/s11894-999-0013-7

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN： 1522-8037


  27 in total

1.  Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.

Authors:  K McColl; L Murray; E El-Omar; A Dickson; A El-Nujumi; A Wirz; A Kelman; C Penny; R Knill-Jones; T Hilditch
Journal:  N Engl J Med       Date:  1998-12-24       Impact factor: 91.245

2.  The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole.

Authors:  J Huang; R H Hunt
Journal:  Aliment Pharmacol Ther       Date:  1999-06       Impact factor: 8.171

3.  Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer.

Authors:  J A Ducóns; S Santolaria; R Guirao; M Ferrero; M Montoro; F Gomollón
Journal:  Aliment Pharmacol Ther       Date:  1999-06       Impact factor: 8.171

4.  Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials.

Authors:  L Laine; R J Hopkins; L S Girardi
Journal:  Am J Gastroenterol       Date:  1998-09       Impact factor: 10.864

5.  A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.

Authors:  N D Yeomans; Z Tulassay; L Juhász; I Rácz; J M Howard; C J van Rensburg; A J Swannell; C J Hawkey
Journal:  N Engl J Med       Date:  1998-03-12       Impact factor: 91.245

6.  Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

Authors:  C J Hawkey; J A Karrasch; L Szczepañski; D G Walker; A Barkun; A J Swannell; N D Yeomans
Journal:  N Engl J Med       Date:  1998-03-12       Impact factor: 91.245

7.  The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy.

Authors:  S J Zanten; M Bradette; A Farley; D Leddin; T Lind; P Unge; E Bayerdörffer; R C Spiller; C O'Morain; P Sipponen; M Wrangstadh; L Zeijlon; P Sinclair
Journal:  Aliment Pharmacol Ther       Date:  1999-03       Impact factor: 8.171

8.  Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.

Authors:  T Lind; S Veldhuyzen van Zanten; P Unge; R Spiller; E Bayerdörffer; C O'Morain; K D Bardhan; M Bradette; N Chiba; M Wrangstadh; C Cederberg; J P Idström
Journal:  Helicobacter       Date:  1996-09       Impact factor: 5.753

9.  Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries.

Authors:  D Y Graham; E Adam; G T Reddy; J P Agarwal; R Agarwal; D J Evans; H M Malaty; D G Evans
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

Review 10.  Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview.

Authors:  S J Veldhuyzen van Zanten; P M Sherman
Journal:  CMAJ       Date:  1994-01-15       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.